INTRODUCTION AND OBJECTIVES: Despite variable clinical concerns and visit types, ambulatory clinic appointments are typically scheduled in fixed increments, resulting in suboptimal time utilization. Advanced analytics are being utilized to improve process efficiency in many industries, but are rarely applied to address operational challenges in ambulatory clinical settings. We sought to develop a machine learning (ML) model that predicts the time pediatric urologists require to see patients and to apply this model to create a more efficient clinic schedule template.
INTRODUCTION AND OBJECTIVES: Despite variable clinical concerns and visit types, ambulatory clinic appointments are typically scheduled in fixed increments, resulting in suboptimal time utilization. Advanced analytics are being utilized to improve process efficiency in many industries, but are rarely applied to address operational challenges in ambulatory clinical settings. We sought to develop a machine learning (ML) model that predicts the time pediatric urologists require to see patients and to apply this model to create a more efficient clinic schedule template.
METHODS: We prospectively collected data from 294 clinic MD visits from January-April 2018. Variables collected included: demographics, physician, visit date/time, new/return visit, urologic surgical history, 1st post-op visit, same-day testing/imaging, and diagnosis. Timestamps were recorded at patient check-in, MD in and out of room, and final check-out. The primary outcome was MD face time, defined as time of MD-out minus time MD-in.
Univariate analysis was performed between predictors and the outcome. Data were split into train/test in 4:1 ratio. Two separate models were created for new and return visits with 1 extra variable (time since last visit) for returns. Gradient boosted machine was chosen as prediction algorithm. Hyperparameters were tuned using 5-fold cross validations within train set.
Two out-of-sample clinic days were chosen to compare the patient wait time between classic (fixed 15 min) and ML strategies. Simulation of patient punctuality was performed 1000 times in each clinic day.
RESULTS: 256 visits (113 new/143 return) were included in the final analysis. Mean age at visit was 6.47 years. In univariate analysis, longer visits were significantly associated with new patients (p<0.01), same-day testing (p<0.01), older patients, and diagnoses such as voiding dysfunction, scrotal complaints, and neurogenic bladder. Conversely, morning clinic, previous urologic surgery (p<0.01), 1st post-op visit (p<0.01), and diagnoses such as penile complaints, undescended testis, and hydrocele were associated with shorter visits. Our ML model predicted MD in-room time accurately to within 3.5AE2.3 minutes. Using the prediction model on 1000 simulated visit days with random patient punctuality, we were able to reduce the wait time by 24-54% (>90% simulations ML classic wait time).
CONCLUSIONS: Pediatric urologist's face time can be accurately predicted with machine learning models. This insight can be incorporated into a robust dynamic scheduling model to minimize patient wait time, maximize face time, increase clinical efficiency, and likely improve family satisfaction.
Source of Funding: Dr. Wang is supported by AHRQ grant # T32-HS000063-24. The funder had no role the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
MP33-19 A FIVE-YEAR SINGLE INSTITUTION EXPERIENCE INTEGRATING TELEHEALTH INTO UROLOGIC CARE DELIVERY
Alex Nourian*, Philadelphia, PA; Nicholas Smith, Jeremy Shelton, Los Angeles, CA INTRODUCTION AND OBJECTIVES: Telehealth is a wellreceived and effective tool in urology, but few studies have described how it can be combined with face-to-face (FTF) visits in the care of urologic conditions. We describe our experience in the Veterans Affairs Greater Los Angeles Healthcare System with the use of telehealth in delivering urologic care, which included a general urology clinic and an erectile dysfunction education clinic. To further examine the way primary care (PC), telehealth and FTF visits were utilized together to provide care, we examined the patient course through three common urologic referrals: elevated prostate-specific antigen (PSA), microscopic hematuria, and obstructive lower urinary tract symptoms (LUTS).
METHODS: We performed a retrospective review of telemedicine visits from 2013 to 2018 to assess patients' presenting urologic condition to telehealth, as well as the number of subsequent telemedicine and in-person encounters. To illustrate how telehealth, FTF visits and PC were integrated into patient care, we used a random convenience sample of 20 patients from each of the three common referrals listed above and reviewed their care over a two-year period following the initial referral to telehealth, and described the site of care delivery for the following key components of care: history and physical, laboratory tests, imaging and procedures.
RESULTS: 811 unique patients were evaluated through telehealth for a total of 2008 telehealth visits. The most common conditions evaluated at the initial encounter were sexual dysfunction (26.8%), LUTS (20.6%), hematuria (15.0%), prostate cancer (13.3%), an elevated PSA (12.1%), stones (2.5%), renal masses (1.7%), and urinary tract infections (1.7%). 34% of patients were managed with telehealth alone, while 64% were seen via telehealth and FTF encounters. The mean number of telehealth to FTF visits was similar (2.48 versus 2.42, respectively). Table 1 shows the proportion of each aspect of care delivered for each condition by setting: in PC, urologic telehealth and FTF visits.
CONCLUSIONS: Telehealth was utilized for a wide array of diseases and was often used in conjunction with FTF visits to capture the components of evaluation for three disease states, suggesting a novel model for urologic care delivery.
Source of Funding: None

MP33-20 THE GAP OF FRAILTY PREDICTS ONCOLOGICAL OUTCOMES IN PATIENTS WITH UROLOGICAL CANCERS: A COMPARISON OF COMMUNITY-DWELLING POPULATION
Osamu Soma*, Shingo Hatakeyama, Hayato Yamamoto, Atsushi Imai, Takahiro Yoneyama, Yasuhiro Hashimoto, Hirosaki, Japan; Takuya Koie, Gifu, Japan; Chikara Ohyama, Hirosaki, Japan INTRODUCTION AND OBJECTIVES: Although measuring frailty is important to estimate risks and to aid shared decision making, there is still no consensus regarding which items or tools should be used to measure frailty. We investigated whether the gap of frailty values between community-dwelling population and tumor-bearing cancer patients predict prognosis in patients with urological cancer, as a quantitative frailty evaluation in cancer patients remain challenging.
METHODS: Frailty assessment was performed in 521 cancer patients presenting to our university hospital between August 2013 to March 2016. Frailty was assessed using a validated tool that included
